Overexpression of CIP2A is associated with poor prognosis in multiple myeloma

Cancerous inhibitor of protein phosphatase 2A (CIP2A), an endogenous protein phosphatase 2A (PP2A) inhibitor, has been identified as an oncoprotein in promoting cancer initiation and progression of several types of cancer. However, the expression and the role played by CIP2A in the pathogenesis of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuewen, Cao, Wei, Qin, Shanshan, Zhang, Te, Zheng, Junnian, Dong, Ying, Ming, Pinghong, Cheng, Qian, Lu, Zheng, Guo, Yang, Zhang, Baofu, Liu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661621/
https://www.ncbi.nlm.nih.gov/pubmed/29263916
http://dx.doi.org/10.1038/sigtrans.2017.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661621/
https://www.ncbi.nlm.nih.gov/pubmed/29263916
http://dx.doi.org/10.1038/sigtrans.2017.13

Ejemplares similares